EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces the appointment of Investec Bank plc as joint corporate broker, with immediate effect to work alongside its existing nominated adviser and broker, N+1 Singer.
Julian Baines, CEO of EKF, commented:
'We outlined at our AGM last month a strategy to deliver significant earnings growth over the next 3 to 4 years and we are delighted to have the support of both N+1 Singer and Investec as our joint brokers as we enter into this next phase of accelerated growth.'
Enquiries:
EKF Diagnostics Holdings plc |
www.ekfdiagnostics.com Tel: 00 44 29 2071 0570 |
N+1 Singer (Nomad & Broker) Aubrey Powell / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking) | Tel: 020 7496 3000 |
Walbrook PR Limited |
Tel: 020 7933 8780 or Mob: 07980 541 893 / 07584 391 303 |
Attachments
- Original document
- Permalink
Disclaimer
EKF Diagnostics Holdings plc published this content on 16 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 June 2021 07:43:03 UTC.